From: In vitro and in vivo evaluation of pharmacological potential of Begonia barbata Wall
Treatment | Writhing count | Average writhing | % Inhibition of writhing | ||
---|---|---|---|---|---|
M-1 | M-2 | M-3 | |||
Control (1% Tween 80) | 17 | 19 | 17 | 17.66 | - |
Standard (50 mg/kg) | 4 | 5 | 7 | 5.33 | 69.82 |
PEF (200 mg/kg) | 14 | 10 | 10 | 11.33 | 35.84 |
PEF (400 mg/kg) | 7 | 6 | 5 | 6 | 66.02 |
DCMF (200 mg/kg) | 8 | 7 | 10 | 8.33 | 52.83 |
DCMF (400 mg/kg) | 5 | 9 | 5 | 6.33 | 64.16 |
EAF (200 mg/kg) | 9 | 14 | 10 | 11 | 37.72 |
EAF (400 mg/kg) | 10 | 8 | 7 | 8.33 | 52.83 |